30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United Kingdom Biotechnology & Medical Research

Arecor Therapeutics PLC (AREC)

Track

The most recent insider trading activity occurred on August 4, 2022, with multiple executives and directors making share purchases. These transactions represent the latest reported insider buying, with a total of 42,666 shares acquired by various individuals, including the Chief Financial Officer, Chief Executive Officer, and several Non-executive Directors.
Stock chart
Ticker: AREC Exchange: LSE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Christine Soden
Non-executive Director
1 purchase — total 20,001 GBP
Buy 4 Aug 2022
Value £2,887,311.71 | Price 365.88 | Shares 19,856
Buy 4 Aug 2022
Value £4,863,314.25 | Price 420.70 | Shares 42,417
Buy 4 Aug 2022
Value £23,268.00 | Price 3.00 | Shares 7,756
Buy 4 Aug 2022
Value £19,998.00 | Price 3.00 | Shares 6,666
Buy 4 Aug 2022
Value £10,002.00 | Price 3.00 | Shares 3,334
Buy 4 Aug 2022
Value £19,998.00 | Price 3.00 | Shares 6,666
Buy 29 Jun 2021
Value £29,410.25 | Price 2.35 | Shares 12,515
Buy 8 Jun 2021
Value £49,719.77 | Price 2.43 | Shares 20,503
Buy 8 Jun 2021
Value £30,337.50 | Price 2.43 | Shares 12,500
Buy 8 Jun 2021
Value £30,337.50 | Price 2.43 | Shares 12,500
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-08-04 2022-08-04 B Purchase
3.2
Christine Soden

Non-executive Director

Executive Director
19,856
365.88
£2,887,312 		19,856 365.88 £2,887,312
2022-08-04 2022-08-04 B Purchase
2.0
Jeremy Morgan

Non-executive Director

Executive Director
42,417
420.70
£4,863,314 		42,417 420.70 £4,863,314
2022-08-04 2022-08-04 B Purchase
0.7
Sam Fazeli

Non-executive Director

Executive Director
62,724
323.80
£836,393 		62,724 323.80 £836,393
2022-08-04 2022-08-04 B Purchase
2.1
Andrew Richards

Chair

Director
6,666
3.00
£19,998 		6,666 3.00 £19,998
2022-08-04 2022-08-04 B Purchase
2.8
Susan Lowther

Chief Financial Officer

Officer
3,334
3.00
£10,002 		3,334 3.00 £10,002
2022-08-04 2022-08-04 B Purchase
1.0
Sarah Howell

Chief Executive Officer

Officer
6,666
3.00
£19,998 		6,666 3.00 £19,998
2021-06-29 2021-06-29 B Purchase
2.8
Susan Lowther

Chief Financial Officer

Officer
12,515
2.35
£29,410 		12,515 2.35 £29,410
2021-06-09 2021-06-08 B Purchase
2.0
Jeremy Morgan

Non-Executive Director

Executive Director
20,503
2.43
£49,720 		20,503 2.43 £49,720
2021-06-09 2021-06-08 B Purchase
3.2
Christine Soden

Non-Executive Director

Executive Director
12,500
2.43
£30,338 		12,500 2.43 £30,338
2021-06-09 2021-06-08 B Purchase
2.1
Andrew Richards

Non-Executive Chairman

Director
12,500
2.43
£30,338 		12,500 2.43 £30,338
Explore more

More insider trading research around Arecor Therapeutics PLC

More insider trades in United Kingdom
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe